Europe Diabetes Care Devices Market
No. of Pages: 157 | Report Code: TIPRE00005737 | Category: Life Sciences
No. of Pages: 157 | Report Code: TIPRE00005737 | Category: Life Sciences
The Europe diabetes care devices market is expected to grow from US$ 8,371.49 million in 2022 to US$ 11,914.05 million by 2028; it is estimated to grow at a CAGR of 4.5% from 2022 to 2028.
Diabetes is a deadly chronic disease with no specialized cure. It is primarily caused by the body’s inability to produce or effectively use the hormone insulin. This inability prevents the body from adequately regulating blood glucose levels. There are two forms of diabetes—diabetes type-I or diabetes insipidus and diabetes type-2 or diabetes mellitus. There is a steady increase in the incidence of diabetes across Europe. Type 2 diabetes is the most prevalent type of diabetes and has increased with cultural and societal changes. In high-income countries, ~91% of adults have type 2 diabetes. As per the International Diabetes Federation (IDF), diabetes affected millions of persons aged 20-79 in 2021. Diabetes can lead to several complications in various body parts and raise the overall risk of premature death. Heart attack, stroke, kidney failure, leg amputation, vision loss, and nerve damage are a few major complications associated with diabetes. Hence, patients suffering from this disease require frequent monitoring and external administration of insulin. The growing prevalence of diabetes is fueling the growth of the diabetes care devices market across the region.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe diabetes care devices market. The Europe diabetes care devices market is expected to grow at a good CAGR during the forecast period.
Europe Diabetes Care Devices Market Revenue and Forecast to 2028 (US$ Million)
Europe Diabetes Care Devices Market Segmentation
The Europe diabetes care devices market is segmented based on type, end user, and country. Based on type, the market is bifurcated into glucose monitoring devices and insulin delivery devices. The glucose monitoring devices segment would dominate the market in 2022. The glucose monitoring devices segment is further divided into testing strips, glucometer, lancets, and others. Similarly, the insulin delivery devices segment is segmented into insulin pens, insulin syringes, insulin pumps, and others. Based on end user, the Europe diabetes care devices market is bifurcated into homecare and hospitals & clinics. The homecare segment would dominate the market in 2022. Based on country, the Europe diabetes care devices market has been categorized into the UK, Germany, France, Italy, Spain, and the Rest of Europe. The Rest of Europe would dominate the market in 2022.
B. Braun Melsungen AG; BD; Dexcom, Inc.; Eli Lilly and Company.; F. Hoffmann-La Roche Ltd.; Insulet Corporation; Medtronic; Novo Nordisk A/S; Tandem Diabetes Care Inc.; and Terumo Corporation are among the leading companies in the Europe diabetes care devices market.
Strategic insights for the Europe Diabetes Care Devices provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
Report Attribute | Details |
---|---|
Market size in 2022 | US$ 8,371.49 Million |
Market Size by 2028 | US$ 11,914.05 Million |
Global CAGR (2022 - 2028) | 4.5% |
Historical Data | 2020-2021 |
Forecast period | 2023-2028 |
Segments Covered |
By Type
|
Regions and Countries Covered | Europe
|
Market leaders and key company profiles |
The geographic scope of the Europe Diabetes Care Devices refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The Europe Diabetes Care Devices Market is valued at US$ 8,371.49 Million in 2022, it is projected to reach US$ 11,914.05 Million by 2028.
As per our report Europe Diabetes Care Devices Market, the market size is valued at US$ 8,371.49 Million in 2022, projecting it to reach US$ 11,914.05 Million by 2028. This translates to a CAGR of approximately 4.5% during the forecast period.
The Europe Diabetes Care Devices Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Diabetes Care Devices Market report:
The Europe Diabetes Care Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Diabetes Care Devices Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Diabetes Care Devices Market value chain can benefit from the information contained in a comprehensive market report.